BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19740680)

  • 41. Results of autologous stem cell transplantation for AL amyloidosis in one Czech center.
    Ryšavá R; Straub J; Vacková B; Kořen J; Trněný M; Potyšová Z; Špička I
    Amyloid; 2011 Jun; 18 Suppl 1():139-41. PubMed ID: 21838464
    [No Abstract]   [Full Text] [Related]  

  • 42. Cardiac amyloidosis with the E526V mutation of the fibrinogen A alpha-chain.
    Mourad G; Delabre JP; Garrigue V
    N Engl J Med; 2008 Dec; 359(26):2847-8. PubMed ID: 19109585
    [No Abstract]   [Full Text] [Related]  

  • 43. Emerging Advances in the Management of Cardiac Amyloidosis.
    Vranian MN; Sperry BW; Valent J; Hanna M
    Curr Cardiol Rep; 2015 Nov; 17(11):100. PubMed ID: 26374453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical study of immunoglobulin light chains and inflammatory cells in a patient with localized primary cutaneous nodular amyloidosis.
    Cai YX; Li SJ; Zhou Y; Li W; Fan YM
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):469-70. PubMed ID: 25399683
    [No Abstract]   [Full Text] [Related]  

  • 45. Late onset renal failure and nephrotic syndrome after autologous stem cell transplant for Al amyloidosis.
    Rifkin SI; Weinstein SS
    Ren Fail; 2012; 34(5):664-6. PubMed ID: 22452410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis.
    Binotto G; Cillo U; Trentin L; Piazza F; Zaninotto M; Semenzato G; Adami F
    Amyloid; 2011 Jun; 18 Suppl 1():132-4. PubMed ID: 21838461
    [No Abstract]   [Full Text] [Related]  

  • 47. Renal transplantation in light chain amyloidosis: coming out of the cupboard.
    Bridoux F; Ronco P; Gillmore J; Fermand JP
    Nephrol Dial Transplant; 2011 Jun; 26(6):1766-8. PubMed ID: 21486870
    [No Abstract]   [Full Text] [Related]  

  • 48. Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation.
    Stangou AJ; Banner NR; Hendry BM; Rela M; Portmann B; Wendon J; Monaghan M; Maccarthy P; Buxton-Thomas M; Mathias CJ; Liepnieks JJ; O'Grady J; Heaton ND; Benson MD
    Blood; 2010 Apr; 115(15):2998-3007. PubMed ID: 19633201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary localised cutaneous amyloidosis--a systematic review.
    Kaltoft B; Schmidt G; Lauritzen AF; Gimsing P
    Dan Med J; 2013 Nov; 60(11):A4727. PubMed ID: 24192243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary localized cutaneous nodular amyloidosis of the feet: a case report and review of the literature.
    Ritchie SA; Beachkofsky T; Schreml S; Gaspari A; Hivnor CM
    Cutis; 2014 Feb; 93(2):89-94. PubMed ID: 24605345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal pulmonary
    Pittman S; Sethi P; Flavell RR; De Marco T; Hernandez Pampaloni M
    J Nucl Cardiol; 2018 Oct; 25(5):1865-1868. PubMed ID: 29101671
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum free light chain trends between orthotopic heart transplantation and auto-SCT in patients with AL amyloidosis.
    Renteria AS; Sanchorawala V; Niehaus ED; Sun F; Semigran MJ; Seldin DC
    Bone Marrow Transplant; 2015 Jun; 50(6):868-9. PubMed ID: 25751645
    [No Abstract]   [Full Text] [Related]  

  • 53. MCP-1 as an effector of IL-31 signaling in familial primary cutaneous amyloidosis.
    Shiao YM; Chung HJ; Chen CC; Chiang KN; Chang YT; Lee DD; Lin MW; Tsai SF; Matsuura I
    J Invest Dermatol; 2013 May; 133(5):1375-8. PubMed ID: 23303452
    [No Abstract]   [Full Text] [Related]  

  • 54. Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis.
    Razonable RR; Patel R; Wilhelm MP; Gertz MA; Litzow MR; Inwards DJ; Dearani JA; Edwards BS; McGregor CG
    Am J Transplant; 2001 May; 1(1):93-5. PubMed ID: 12095046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyloid heart disease.
    Dubrey SW; Falk RH
    Br J Hosp Med (Lond); 2010 Feb; 71(2):76-82. PubMed ID: 20220694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nodular localized cutaneous amyloidosis in an immunosuppressed patient.
    Yong AS; Murphy JG; Shah N
    Int J Dermatol; 2015 Jun; 54(6):708-9. PubMed ID: 23786248
    [No Abstract]   [Full Text] [Related]  

  • 57. Heart transplantation in cardiac storage diseases: data on Fabry disease and cardiac amyloidosis.
    Di Nora C; Livi U
    Curr Opin Organ Transplant; 2020 Jun; 25(3):211-217. PubMed ID: 32304420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary cutaneous nodular amyloidosis associated with psoriasis.
    Ung CY; Carr NJ; Ardern-Jones MR
    Clin Exp Dermatol; 2014 Jul; 39(5):608-11. PubMed ID: 24888341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic lymphocytic leukemia: cutaneous involvement associated with nodular amyloidosis.
    Blixt EK; Brewer JD
    Int J Dermatol; 2015 Jun; 54(6):e230-2. PubMed ID: 25039892
    [No Abstract]   [Full Text] [Related]  

  • 60. Hereditary apolipoprotein A1 amyloidosis with cutaneous and cardiac involvement: a long familial history.
    Muscardin L; Cota C; Donati P; Sinagra JL; Paulli M; Merlini G; Verga L; Obici L; Capello GL
    Eur J Dermatol; 2014; 24(2):261-3. PubMed ID: 24682578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.